Flagship Pioneering, LLC - 10%+ Owner at Omega Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
OMGA
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Flagship Pioneering, LLC since 09 Mar 2025

Holdings reported by Flagship Pioneering, LLC for Omega Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,617,413 $68,939,304 $8.00 27 Feb 2023 By Flagship Pioneering Fund VI, L.P.
Common Stock 7,508,693 $60,069,544 $8.00 27 Feb 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Common Stock 5,896,386 $47,171,088 $8.00 27 Feb 2023 By Flagship Ventures Fund V, L.P.
Common Stock 2,197,059 $17,576,472 $8.00 27 Feb 2023 By Flagship VentureLabs V, LLC
Common Stock 1,617,646 $12,941,168 $8.00 27 Feb 2023 By FPN, L.P.
Common Stock 1,617,646 $12,941,168 $8.00 03 Aug 2021 Indirect
Common Stock 1,329,324 $10,634,592 $8.00 27 Feb 2023 By Flagship Pioneering Fund VII, L.P.
Common Stock 1,088,470 $8,707,760 $8.00 27 Feb 2023 By Flagship V VentureLabs Rx Fund, L.P.
Common Stock 970,588 $7,764,704 $8.00 27 Feb 2023 By Nutritional Health LTP Fund, L.P.
Series A Convertible Preferred Stock 0 03 Aug 2021 Indirect Common Stock
Series B Convertible Preferred Stock 0 03 Aug 2021 Indirect Common Stock
Series C Convertible Preferred Stock 0 03 Aug 2021 Indirect Common Stock

Transactions reported by Flagship Pioneering, LLC for Omega Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.